Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI).

Sanders M, Hong E, Chung PS, Rao AP, Cohn W, Beringer P.

DOI: 10.1016/j.jcf.2025.09.002
Published: 2025-09-16
Container: J Cyst Fibros
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jcf.2025.09.002,
  title = {Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI).},
  author = {Sanders M and  Hong E and  Chung PS and  Rao AP and  Cohn W and  Beringer P.},
  year = {2026},
  journal = {J Cyst Fibros},
  doi = {10.1016/j.jcf.2025.09.002},
  url = {https://doi.org/10.1016/j.jcf.2025.09.002}
}

RIS

TY  - JOUR
TI  - Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI).
AU  - Sanders M
AU  -  Hong E
AU  -  Chung PS
AU  -  Rao AP
AU  -  Cohn W
AU  -  Beringer P.
PY  - 2026
JO  - J Cyst Fibros
DO  - 10.1016/j.jcf.2025.09.002
UR  - https://doi.org/10.1016/j.jcf.2025.09.002
ER  -

APA

M, S., E, H., PS, C., AP, R., W, C., & P., B. (2026). Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI).. J Cyst Fibros. https://doi.org/10.1016/j.jcf.2025.09.002

Source records

europe-pmc · retrieved 2026-09-26T19:57:44.049Z